Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2003 1
2004 2
2005 4
2006 2
2007 8
2008 9
2009 6
2010 4
2011 9
2012 10
2013 12
2014 11
2015 11
2016 13
2017 19
2018 16
2019 13
2020 14
2021 10
2022 9
2023 13
2024 10
2025 12
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Results by year

Filters applied: . Clear all
Page 1
Exome sequencing points to pathogenic ATM variants in gastric cancer.
Koebbe LL, Hess T, Haas SL, Gockel I, Piessen G, Latiano A, Pereira C, Malecka-Wojciesko E, Mokrowiecka A, Boccia S, Majewski M, Alakus H, Lanas Á, Pastorino R, Goetze TO, Elbe P, Kreuser N, Palmieri O, Tavano F, Bruns CJ, Glehen O, B D'Journo X, Gronnier C, Fabre JM, Sulpice L, Bujanda L, Moreira L, Heilmann-Heimbach S, Billmann M, Noethen MM, Cannizzaro R, Ghidini M, Hamann L, Aragones N, Dinis-Ribeiro M, Medeiros R, Al-Batran SE, Leja M, Kupcinskas J, García-González MA, Maj C, Venerito M, Schumacher J. Koebbe LL, et al. Among authors: al batran se. Eur J Hum Genet. 2025 Dec 26. doi: 10.1038/s41431-025-01994-8. Online ahead of print. Eur J Hum Genet. 2025. PMID: 41454052
Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study).
Goetze TO, Al-Batran SE, Liersch R, Scheuer L, Goehler T, Kaiser U, Denzlinger C, Brandl S, Pink D, Uhlig J, Maasberg M, Loose M, Schaaf M, Sookthai D, Zäpf B, Pauligk C, Habibzade T, Hofheinz RD, Koch C; AIO Study Group. Goetze TO, et al. Among authors: al batran se. Int J Cancer. 2025 Dec 13. doi: 10.1002/ijc.70280. Online ahead of print. Int J Cancer. 2025. PMID: 41388765
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.
Heinrich K, Stintzing S, Weikersthal LFV, Decker T, Kiani A, Kaiser F, Al-Batran SE, Heintges T, Lerchenmüller C, Kahl C, Seipelt G, Kullmann F, Moehler M, Scheithauer W, Jung A, Holch JW, Held S, Modest DP, Heinemann V. Heinrich K, et al. Among authors: al batran se. Eur J Cancer. 2026 Jan;232:116133. doi: 10.1016/j.ejca.2025.116133. Epub 2025 Nov 22. Eur J Cancer. 2026. PMID: 41319450 Free article. Clinical Trial.
Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial.
Stein A, Goekkurt E, Al-Batran SE, Moosmann N, Ettrich TJ, Goetze T, Gruen B, Homann N, Lorenzen S, Hofheinz RD, Rempel V, Siegler G, Müller C, Thiele B, Broering T, Cruz MS, Pauligk C, Binder M, Tintelnot J. Stein A, et al. Among authors: al batran se. Nat Med. 2025 Dec;31(12):4197-4204. doi: 10.1038/s41591-025-03979-y. Epub 2025 Oct 18. Nat Med. 2025. PMID: 41109919 Free PMC article. Clinical Trial.
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study.
Shitara K, Rha SY, Wyrwicz L, Oshima T, Karaseva N, Osipov M, Yasui H, Yabusaki H, Afanasyev S, Park YK, Al-Batran SE, Yoshikawa T, Yanez P, Pietrantonio F, Lonardi S, Fang X, Guan Y, Valderrama A, Leconte P, Bhagia P, Bang YJ; KEYNOTE-585 Investigators. Shitara K, et al. Among authors: al batran se. J Clin Oncol. 2025 Oct 10;43(29):3152-3159. doi: 10.1200/JCO-25-00486. Epub 2025 Aug 19. J Clin Oncol. 2025. PMID: 40829093 Clinical Trial.
Individually compounded multi-chamber vs. standardized parenteral nutrition bags in solid tumors-A randomized clinical trial (IKF-010).
Goetze TO, Hofheinz RD, Roetzer I, Blau W, Zander T, Luley KB, Ivanyi P, Groschek M, Kreiss-Sender J, Baur C, Wolff T, Wenning B, Behringer D, Weißinger F, Kunitz A, Tschechne B, Decker-Baumann C, Frank M, Wohn L, Riedel J, Sookthai D, Schaaf M, Al-Batran SE, Haag GM; AIO Study Group. Goetze TO, et al. Among authors: al batran se. Clin Nutr ESPEN. 2025 Oct;69:106-114. doi: 10.1016/j.clnesp.2025.06.040. Epub 2025 Jun 24. Clin Nutr ESPEN. 2025. PMID: 40571097 Free article. Clinical Trial.
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer.
Janjigian YY, Al-Batran SE, Wainberg ZA, Muro K, Molena D, Van Cutsem E, Hyung WJ, Wyrwicz L, Oh DY, Omori T, Moehler M, Garrido M, Oliveira SCS, Liberman M, Oliden VC, Smyth EC, Stein A, Bilici M, Alvarenga ML, Kozlov V, Rivera F, Kawazoe A, Serrano O, Heilbron E, Negro A, Kurland JF, Tabernero J; MATTERHORN Investigators. Janjigian YY, et al. Among authors: al batran se. N Engl J Med. 2025 Jul 17;393(3):217-230. doi: 10.1056/NEJMoa2503701. Epub 2025 Jun 1. N Engl J Med. 2025. PMID: 40454643 Clinical Trial.
Guidelines of Onkopedia: What Is New?
Scheck MK, Al-Batran SE, Borner M, Gockel I, Götze TO, Grenacher L, Hass HG, Köberle D, Moehler M, Porschen R, Pritzkuleit R, Rumpold H, Sinn M, Stuschke M, Thuss-Patience P, Maschmeyer G, Wörmann B, Lorenzen S. Scheck MK, et al. Among authors: al batran se. Oncol Res Treat. 2025;48(10):655-662. doi: 10.1159/000546550. Epub 2025 May 30. Oncol Res Treat. 2025. PMID: 40451170 Free article.
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer.
Weiss L, Stintzing S, Stahler A, Benedikt Westphalen C, von Weikersthal LF, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran SE, Heintges T, Lerchenmüller CA, Kahl C, Seipelt G, Kullmann F, Heinrich K, Holch JW, Alig A, Jung A, Modest DP, Heinemann V. Weiss L, et al. Among authors: al batran se. Eur J Cancer. 2025 May 15;221:115399. doi: 10.1016/j.ejca.2025.115399. Epub 2025 Apr 4. Eur J Cancer. 2025. PMID: 40222201 Free article. Clinical Trial.
189 results